Related Experiment Videos
Interventional therapy in heart failure management
K Marzo1, F M Prigent, R M Steingart
1Cardiac Catheterization Laboratory, Division of Cardiology, Department of Medicine, Winthrop-University Hospital, Mineola, NY 11501, USA.
Insights
Congestive heart failure (CHF) is rising due to aging populations and better survival from heart disease. Interventional therapies may offer new hope for managing CHF symptoms and improving outcomes.
Area of Science:
- Cardiology
- Geriatrics
- Public Health
Background:
- Rising incidence and prevalence of congestive heart failure (CHF) in the US.
- Aging population and decreased mortality from coronary artery disease (CAD) and hypertensive heart disease (HHD) contribute to increased CHF.
- Current maximal medical therapy offers limited improvement in quality of life and lifespan for symptomatic CHF patients.
Purpose of the Study:
- To explore the applicability of interventional therapies in managing congestive heart failure.
- To assess the potential benefits of interventional approaches for elderly patients with CHF.
- To address the use of interventions for CHF caused by CAD, valvular heart disease, or renal vascular disease.
Main Methods:
- Review of current interventional strategies for cardiovascular diseases.
- Analysis of potential application of these strategies to CHF management.
- Focus on elderly patient populations with specific CHF etiologies.
Main Results:
- Interventional therapies have revolutionized ischemic cardiovascular disease management.
- The potential for similar benefits in CHF requires further investigation.
- Specific interventional approaches for elderly CHF patients are under consideration.
Conclusions:
- The increasing burden of CHF necessitates exploring novel treatment paradigms.
- Interventional cardiology offers a promising avenue for improving CHF outcomes.
- Further research is warranted to establish the efficacy and safety of interventional therapies for CHF.
Abstract:
The incidence and prevalence of congestive heart failure are rapidly increasing because of the progressive decrease in age-adjusted mortality rates for coronary artery disease and hypertensive heart disease, together with the progressive aging of the US population. Despite great advances in maximal medical therapy, most patients with symptomatic congestive heart failure can expect functional impairment, interludes of worsening symptomatology, and a shortened life span. Thus, it is appropriate to ask whether the interventional revolution that is under way for the management of ischemic cardiovascular disease can be applied with benefit to the management of congestive heart failure. The use of interventional therapies for the treatment of elderly patients with congestive heart failure caused by coronary artery disease, valvular heart disease, or renal vascular disease is addressed.